Dec. 11, 2025
Mizzou Engineering professor named 2025 NAI Fellow
Raghuraman Kannan is among 169 researchers receiving the prestigious honor from the National Academy of Inventors this year.
Sep. 16, 2025
Mizzou Engineering faculty named Curators’ Distinguished Professors
Sheila Grant and Raghuraman Kannan have received the highest honor bestowed by the University of Missouri System.
July 8, 2025
Study: Why some lung cancer treatments stop working — and possible fixes
University of Missouri scientists discover a hidden "molecular seesaw" behind drug resistance in certain types of lung cancer, offering hope for more effective therapies.
Jan. 5, 2023
Department of Chemical and Biomedical Engineering name change reflects research focus
Mizzou Engineering will put more focus on research and innovations around chemical and biomedical innovations in the coming years.
Oct. 19, 2022
Reversing drug resistance in lung cancer
Raghuraman Kannan, right, and a team of researchers at the University of Missouri recently received a $2.35 million grant from the National Cancer Institute (NCI) to generate preclinical data based on their existing research around lung cancer — the required step before human clinical trials can begin. By Eric Stann | MU News Burea When someone is diagnosed with non-small cell lung cancer — one of two main forms of lung cancer — there is a 70-80% chance that after 14 months the cancer will develop a resistance to the drug therapy originally given to fight it. If that happens,…